Vaughn Himes
Direktor/Vorstandsmitglied bei ACHIEVE LIFE SCIENCES, INC.
Vermögen: - $ am 30.06.2024
Aktive Positionen von Vaughn Himes
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ACHIEVE LIFE SCIENCES, INC. | Direktor/Vorstandsmitglied | 14.03.2022 | - |
Independent Dir/Board Member | 14.03.2022 | - | |
VBI VACCINES INC. | Direktor/Vorstandsmitglied | 24.04.2023 | - |
Independent Dir/Board Member | 24.04.2023 | - |
Karriereverlauf von Vaughn Himes
Ehemalige bekannte Positionen von Vaughn Himes
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SEAGEN INC. | Geschäftsführer | 01.04.2009 | 01.07.2012 |
Technik-/Wissenschafts-/F&E-Leiter | 01.08.2016 | 14.12.2023 | |
Corporate Officer/Principal | 01.07.2012 | 01.08.2016 | |
SeaGen International GmbH | Direktor/Vorstandsmitglied | 01.11.2015 | 01.12.2021 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2005 | 01.03.2009 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Corporate Officer/Principal | 01.03.2003 | 01.10.2005 |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01.09.2000 | 01.03.2003 |
Genovo, Inc.
Genovo, Inc. Medical SpecialtiesHealth Technology Part of Innoviva, Inc., Genovo, Inc. is a maker of gene and cell therapy products. The company is based in Sharon Hill, PA. Genovo was acquired by AmpliPhi Biosciences Corp. on September 20, 2000 for $84.53 million. | Corporate Officer/Principal | 01.01.1999 | 01.01.2000 |
Wyeth Lederle Vaccines SA
Wyeth Lederle Vaccines SA Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Wyeth Lederle Vaccines SA develops and manufactures pharmaceutical products. The company is based in Louvain-la-Neuve, Belgium. | Corporate Officer/Principal | - | - |
Ausbildung von Vaughn Himes
Pomona College | Undergraduate Degree |
University of Minnesota | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Belgien | 2 |
Kanada | 2 |
Operativ
Corporate Officer/Principal | 5 |
Director/Board Member | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Sektoral
Health Technology | 9 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ACHIEVE LIFE SCIENCES, INC. | Health Technology |
VBI VACCINES INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
Genovo, Inc.
Genovo, Inc. Medical SpecialtiesHealth Technology Part of Innoviva, Inc., Genovo, Inc. is a maker of gene and cell therapy products. The company is based in Sharon Hill, PA. Genovo was acquired by AmpliPhi Biosciences Corp. on September 20, 2000 for $84.53 million. | Health Technology |
Seagen Inc.
Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Wyeth Lederle Vaccines SA
Wyeth Lederle Vaccines SA Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Wyeth Lederle Vaccines SA develops and manufactures pharmaceutical products. The company is based in Louvain-la-Neuve, Belgium. | Health Technology |
SeaGen International GmbH |
- Börse
- Insiders
- Vaughn Himes
- Erfahrung